Information Journal Paper
APA:
Copy. (2018). Low-dose aspirin at≤ 16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 15(5), 4361-4369. SID. https://sid.ir/paper/767926/en
Vancouver:
Copy. Low-dose aspirin at≤ 16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis. EXPERIMENTAL AND THERAPEUTIC MEDICINE[Internet]. 2018;15(5):4361-4369. Available from: https://sid.ir/paper/767926/en
IEEE:
Copy, “Low-dose aspirin at≤ 16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis,” EXPERIMENTAL AND THERAPEUTIC MEDICINE, vol. 15, no. 5, pp. 4361–4369, 2018, [Online]. Available: https://sid.ir/paper/767926/en